IRIS
ADAMO, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.751
NA - Nord America 3.375
AS - Asia 1.466
SA - Sud America 479
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 37
OC - Oceania 1
Totale 9.152
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.289
RU - Federazione Russa 1.892
SG - Singapore 651
SE - Svezia 526
IE - Irlanda 445
CN - Cina 428
BR - Brasile 418
DE - Germania 170
HK - Hong Kong 152
UA - Ucraina 152
FR - Francia 124
IT - Italia 124
GB - Regno Unito 106
FI - Finlandia 81
VN - Vietnam 60
IN - India 57
PL - Polonia 45
CA - Canada 37
BE - Belgio 23
AR - Argentina 20
BD - Bangladesh 20
ZA - Sudafrica 16
MX - Messico 15
IQ - Iraq 14
CO - Colombia 12
AT - Austria 11
ID - Indonesia 11
VE - Venezuela 11
TR - Turchia 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
MA - Marocco 9
NL - Olanda 9
PK - Pakistan 9
JP - Giappone 7
ES - Italia 6
JM - Giamaica 6
SA - Arabia Saudita 6
DZ - Algeria 5
GT - Guatemala 5
JO - Giordania 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
CR - Costa Rica 4
CW - ???statistics.table.value.countryCode.CW??? 4
EC - Ecuador 4
PR - Porto Rico 4
AL - Albania 3
GP - Guadalupe 3
IL - Israele 3
LT - Lituania 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
AM - Armenia 2
BO - Bolivia 2
CH - Svizzera 2
EE - Estonia 2
EG - Egitto 2
EU - Europa 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AI - Anguilla 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
IM - Isola di Man 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
PH - Filippine 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TH - Thailandia 1
TM - Turkmenistan 1
VC - Saint Vincent e Grenadine 1
Totale 9.123
Salva come PNG Salva come JPEG
Città #
Moscow 523
Dublin 442
Ashburn 433
Singapore 355
Chandler 333
Jacksonville 291
Nyköping 282
Dallas 263
San Jose 209
Beijing 168
Hong Kong 152
Council Bluffs 119
Ann Arbor 85
Los Angeles 82
The Dalles 82
Dearborn 81
New York 75
Cambridge 64
Princeton 64
Medford 61
Lauterbourg 56
Des Moines 51
Boardman 42
São Paulo 42
Warsaw 41
Lancaster 34
Buffalo 32
Pune 29
Frankfurt am Main 27
Messina 26
Phoenix 24
Brussels 23
Tianjin 23
Orem 21
Munich 20
Hanoi 17
Ho Chi Minh City 17
Rio de Janeiro 16
Brooklyn 15
Jinan 15
Santa Clara 15
Guangzhou 14
Wilmington 14
Redondo Beach 13
Shenyang 13
Woodbridge 13
Johannesburg 12
Boston 11
Helsinki 11
Manchester 11
Nanjing 11
Belo Horizonte 10
Chicago 10
Montreal 10
Tashkent 10
Stockholm 9
Vienna 9
Houston 8
London 8
Milan 8
Rome 8
Washington 8
Atlanta 7
Mexico City 7
Nanchang 7
Ningbo 7
Porto Alegre 7
San Mateo 7
Tokyo 7
Amsterdam 6
Baghdad 6
Curitiba 6
Dong Ket 6
Fortaleza 6
Grammichele 6
Haikou 6
Hebei 6
Mumbai 6
Olomouc 6
Poplar 6
Shenzhen 6
Turku 6
Bogotá 5
Campinas 5
Chennai 5
Denver 5
Goiânia 5
Hangzhou 5
Istanbul 5
Jakarta 5
New Delhi 5
Nuremberg 5
Taiyuan 5
Toronto 5
Barbacena 4
Brasília 4
Casablanca 4
Dhaka 4
Guarulhos 4
Guatemala City 4
Totale 5.182
Salva come PNG Salva come JPEG
Nome #
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients 240
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 227
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 222
The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer 213
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis. 205
Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care. 203
Preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes for the assessment of metastasis risk in breast cancer (BC). 188
Interleukin-22 serum concentration in colon-rectal cancer patients and clinical correlations: our experience. 186
Breast. La terapia primaria: stato dell'arte 181
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy. 180
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications. 179
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. 179
Hereditary breast/ovarian cancer families: The impact of mutation prediction models on BRCA1/2 mutation screening costs. 178
The palliative role of Gefitinib (Iressa) in the treatment of heavily pretreated patients with advanced, refractory non small cell lung cancer. Results of a 3-year experience. 170
Combination of Gemcitabine (GEM and Liposomal Pegylate Doxorubicin (PLD) in recurrent/ metastatic breast carcinoma: a phase II study. 165
BRCA1 missense variants of uncertain clinical significance in unaffected and breast/ovarian cancer of the sicilian population. 163
BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models. 162
A Missense Mutation Associated to Early Onset Breast Cancer in A Sicilian Woman. 162
BRCA1 germline mutations in sicilian breast and/or ovarian cancer families and their implications for genetic counseling. 158
AlphaB-crystallin (aBC) expression in breast cancer brain metastases (BM) and primary breast cancer (pBC) with eventual BM and association with outcome 156
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 156
Embolia polmonare 152
A rare case of malignant solitary fibrous tumor of the spinal cord 151
A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation ? 150
Incidence and preferential localizations of bone metastases: biomolecolar and clinical implications. 149
Analysis of the expression levels of Leptin gene and it’s receptor in Breast Cancer patients. 146
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience. 144
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 142
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study) 141
From Adjuvant to Preventive Breast Cancer Treatment: bridging the gap over troubled waters. 139
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. 134
Observational study to evaluate the pattern of trastuzumab (T) use and survival outcomes in HER2-positive (HER2+) early breast cancer (EBC): Regional Southern Italy experience. 132
May the istotype influence the response to pemetrexed in patients with non small cell lung cancer? Preliminary data of our clinical experience. 131
Ruolo del Trastuzumab nel Trattamento Adiuvante del Carcinoma Mammario Operabile. 131
SAFETY AND ACTIVITY OF ERLOTINIB (TARCEVA) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC, REFRACTORY NON SMALL CELL LUNG CANCER 130
Multicenter study in women with infracentimetric HER2 positive breast cancer: The Regional Sicilian experience. 130
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 lymphnodes 129
Infra-centimetric HER2 positive Breast Cancer: The Southern Italy Experience. 128
Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series. 124
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study. 122
Ruolo di Trastuzumab nella terapia adiuvante del carcinoma mammario operabile. 120
Preclinical Development of an Intracranial Triple Negative Breast Cancer (TNBC) Tumor Model: A Pilot Study. 117
Neoplasie della testa collo nell’ anziano 116
Phase II trial ZD1839(IRESSA)second-third line in patients with advanced/metastatic non small cell lung cancer (NSCLC):preliminary results 115
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 negative lymphnodes. 115
Strategia Terapeutica nel Carcinoma Prostatico Ormonorefrattario 113
Tumor Characteristics and Adjuvant treatment in Very Young Women 113
Phosphatidylinositol 3-kinase (PI3K) pathway activation in breast cancer brain metastases. 111
Safety of the combination Capecitabine plus Bevacizumab in the treatment of heavily treated advanced colorectal cancer patients: Our experience. 110
Turbe della nutrizione: anoressia e cachessia. 110
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications 110
Simultaneous development and parallel course of disseminated superficial porokeratosis and ovarian cancer: Coincidental association or true paraneoplastic syndrome? 110
Role of MTHFR polymorphisms as predictive markers of acute toxicity during 5-fluorouracil based chemotherapy for colorectal cancer: Preliminary data. 108
Safety and clinical activity of trastuzumab (TSM) containing therapies in heavily pretreated patients with metastatic breast cancer (MBC): A five-year experience 107
Safety of Zoledronic acid in bone metastatic breast cancer patients: A retrospective analysis. 106
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer. 103
Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels 102
Prognostic significance of elevated pretreatment serum CA-125 in patients (pts) with epithelial ovarian cancer (CEO) treated with surgery and platinum/taxane-based chemotherapy. 102
Primary Therapy in Breast Cancer: The State of the Art. 98
Interleukin-22 serum concentration in colon-rectal cancer patients and clinical correlations: our experience. 96
Stratifying triple-negative breast cancer: which definition(s) to use? 95
Safety and activity of trastuzumab (TRA) containing therapies as treatment of metastatic breast cancer(MBC): a five year experience. 93
SAFETY OF PEGILATED LIPOSOMAL DOXORUBICIN AND GEMCITABINE IN ELDERLY WOMEN (>65 YEARS)WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER 91
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. 69
null 52
null 37
null 33
null 22
Totale 9.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022380 0 0 0 0 21 3 23 13 8 107 66 139
2022/20231.362 98 146 62 103 96 141 29 84 540 5 43 15
2023/2024350 22 49 19 33 30 136 36 1 7 3 4 10
2024/20251.179 9 21 24 73 60 36 10 220 336 72 133 185
2025/20263.859 154 223 250 198 344 917 575 531 469 114 46 38
2026/2027564 46 122 164 225 7 0 0 0 0 0 0 0
Totale 9.152